Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Gastric Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10120-006-0369-4PMID 16767369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study

  2003cited by this paper
• Staging Laparoscopy for Gastric Cancer

  2003cited by this paper
• Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

  2003cited by this paper
• Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

  2003cited by this paper
• Laparoscopy significantly improves the perceived preoperative stage of gastric cancer

  2003cited by this paper
• Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials?

  2002cited by this paper
• Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer

  2002cited by this paper
• Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses.

  2002cited by this paper
• Chemotherapy in gastric cancer: a review and updated meta-analysis.

  2002cited by this paper
• Chemotherapy in gastric cancer: a review and updated meta-analysis

  2002cited by this paper
• De Gramont Schedule is a Very Low Toxic and Effective Regimen in Low Performance Status Patients Affected by Metastatic Gastric Cancer: Preliminary Report

  2002cited by this paper
• Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer

  2002cited by this paper
• Neoadjuvant Chemotherapy followed by Salvage Surgery: Effect on Survival of Patients with Primary Noncurative Gastric Cancer

  2002cited by this paper
• Cancer Statistics, 2001

  2001cited by this paper
• Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

  2001cited by this paper
• Neoadjuvant therapy for patients with locally advanced gastric carcinoma with etoposide, doxirubicin, and cisplatinum

  2001cited by this paper
• Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer

  2001cited by this paper
• Neoadjuvant Chemotherapy With P-ELF (Cisplatin, Etoposide, Leucovorin, 5-Fluorouracil) Followed by Radical Resection in Patients With Initially Unresectable Gastric Adenocarcinoma: A Phase II Study

  2000cited by this paper
• Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

  2000cited by this paper
• Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial. The Dutch Gastric Cancer Group (DGCG).

  1999cited by this paper
• Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer.

  1999cited by this paper
• Estimates of the worldwide mortality from 25 cancers in 1990

  1999cited by this paper
• Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.

  1999cited by this paper
• Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29 (1999).

  1999cited by this paper
• Neoadjuvant chemotherapy in advanced gastric cancer with non-curative factors: a Phase II study with 5-fluorouracil, leucovorin, and cisplatin

  1999cited by this paper
• Japanese Classification of Gastric Carcinoma – 2nd English Edition –

  1998cited by this paper
• Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

  1998cited by this paper
• Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy

  1997cited by this paper
• Combined intensive chemotherapy and radical surgery for incurable gastric cancer

  1997cited by this paper
• Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer.

  1996influential reference
• Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.

  1996cited by this paper
• Neoadjuvant chemotherapy for high-grade advanced gastric cancer

  1993cited by this paper
• Cancer of the stomach. A patient care study by the American College of Surgeons.

  1993cited by this paper
• Rising incidence of adenocarcinoma of the esophagus and gastric cardia.

  1991cited by this paper
• Cancer of the stomach.

  1989cited by this paper

• Immunological Analysis of Prognostic Factors in Conversion Surgery Cases for Gastric Cancer.

  2025cites this paper
• The association between pathological complete response and prognosis of gastric or adenocarcinoma of esophagogastric junction cancer following neoadjuvant chemotherapy: A meta-analysis.

  2025cites this paper
• Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers

  2020cites this paper
• Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules

  2019cites this paper
• Detection of circulating stage III–IV gastric cancer tumor cells based on isolation by size of epithelial tumor: using the circulating tumor cell biopsy technology

  2019cites this paper
• Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy

  2018cites this paper
• Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer

  2017cites this paper
• Conversion therapy for stage IV gastric cancer-the present and future.

  2016cites this paper
• Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer.

  2016cites this paper
• A Case of Long-Term Complete Remission of Advanced Gastric Adenocarcinoma with Liver Metastasis

  2016cites this paper
• Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification

  2015cites this paper
• Outcome of Peritoneal Washing Cytology Results and the Appropriate Management in Thai Patients with Gastric Adenocarcinoma

  2015cites this paper
• Pseudo-Meigs' syndrome caused by a Krukenberg tumour of gastric cancer.

  2015cites this paper
• Circulating Tumor Cells as an Independent Predictor of Survival in Advanced Gastric Cancer

  2015cites this paper
• S-1 for the treatment of gastrointestinal cancer

  2012cites this paper
• Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: report of a case

  2012cites this paper
• Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer

  2012cites this paper
• Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer

  2011cites this paper
• A CASE REPORT OF CURATIVE RESECTION OF ADVANCED GASTRIC CANCER WITH PARAAORTIC LYMPH NODE AND LIVER METASTASES AFTER NEOADJUVANT CHEMOTHERAPY

  2011cites this paper
• A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).

  2010cites this paper
• Gastrojejunostomy followed by induction chemotherapy for incurable gastric cancer with outlet obstruction.

  2010cites this paper
• A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703)

  2010cites this paper
• Laparoscopy-assisted Total Gastrectomy for Advanced Gastric Cancer With Carcinomatous Ascites After S1 Plus Cisplatin Chemotherapy: A Case Report

  2010cites this paper
• Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination

  2009cites this paper
• S-1+CDDPによる術前化学療法にて組織学的CRが得られた胃髄様癌の1例

  2009cites this paper
• The effect of neoadjuvant chemotherapy for advanced gastric cancer

  2009cites this paper
• The effect of seed aging on the seedling growth as affected by environmental factors in wheat.

  2009cites this paper
• Induction Chemotherapy with S-1 Plus Cisplatin Followed by Surgery for Treatment of Gastric Cancer with Peritoneal Dissemination

  2009cites this paper
• Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer.

  2009cites this paper
• Salvage Gastrectomy Following a Combination of Biweekly Paclitaxel and S-1 for Stage IV Gastric Cancer

  2008cites this paper
• S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer

  2008cites this paper
• Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer

  2008cites this paper
• Advanced gastric cancer showing complete remission of metastatic lymph node after chemotherapy.

  2007cites this paper
• 1コースのTS-1/CDDPを用いた術前化学療法で組織学的CRが得られた進行胃癌の1例

  2007cites this paper
• Neoadjuvant S-1 and cisplatin for gastric carcinoma: there will be more to come

  2006influential citation
• Gastrointestinal Cancer: Targets and Therapy Dovepress the Role of S-1 in the Treatment of Gastric Cancer

  year unknowncites this paper